American Association for Cancer Research

Press Releases: 2011

Page:   1 2 3 4 5 6 7 8 9 10  next
Results Per Page 

Starch Intake May Influence Risk for Breast Cancer Recurrence

December 8, 2011

SAN ANTONIO — Researchers have linked increased starch intake to a greater risk for breast cancer recurrence, according to results presented at...

Risk for Developing New Cancer in Other Breast Increased for Survivors With BRCA Mutation

December 8, 2011

SAN ANTONIO — Breast cancer survivors who carry the BRCA1 or BRCA2 genetic mutation are at high risk for developing contralateral breast cancer...

Bilateral Oophorectomy Associated With Higher Prevalence of Low Bone Mineral Density and Arthritis in Younger Women

December 8, 2011

SAN ANTONIO — Women who underwent surgery to remove their ovaries before the age of 45 years were more likely to have arthritis and low bone...

Many Women Do Not Undergo Breast Reconstruction After Mastectomy

December 8, 2011

SAN ANTONIO — Despite the benefits, only a small minority of women, regardless of age, are opting for immediate reconstructive breast surgery...

AACR Unveils Cancer Today: Magazine for Patients, Survivors and Caregivers

December 8, 2011

PHILADELPHIA — The American Association for Cancer Research (AACR) welcomes the newest addition to its publication family, Cancer Today.

Intermittent, Low-Carbohydrate Diets More Successful Than Standard Dieting, Present Possible Intervention for Breast Cancer Prevention

December 8, 2011

SAN ANTONIO — An intermittent, low-carbohydrate diet was superior to a standard, daily calorie-restricted diet for reducing weight and lowering...

MRI May Be Noninvasive Method to Measure Breast Cancer Prognosis

December 8, 2011

SAN ANTONIO — Quantitative magnetic resonance imaging measures were associated with prognostic tumor markers, demonstrating the potential of...

Addition of Trastuzumab May Potentially Equalize Disease-Free Survival Outcomes Among Obese and Normal-Weight Patients

December 8, 2011

SAN ANTONIO — A large, multicenter, randomized study has shown that obese patients with HER2-positive breast cancer have larger tumors,...

Exemestane Plus Everolimus Increased Progression-Free Survival for Women With Metastatic Breast Cancer

December 7, 2011

SAN ANTONIO — Everolimus in combination with exemestane has shown promise for the treatment of breast cancer.

Dual HER2 Blockade Significantly Extends Progression-Free Survival

December 7, 2011

SAN ANTONIO — Adding pertuzumab to a combination of trastuzumab and docetaxel chemotherapy extended progression-free survival by a median of...

Addition of Bevacizumab to Conventional Therapy Improved Progression-Free Survival in HER2-Positive Breast Cancer

December 7, 2011

SAN ANTONIO — Data evaluated by an independent review committee revealed that the addition of bevacizumab to trastuzumab and docetaxel...

Breast Cancer Mortality Higher in Hispanic Women

December 7, 2011

SAN ANTONIO — Hispanic women are more likely to die from breast cancer than non-Hispanic white women, according to research presented at the...

Obesity Linked to Worse Outcomes in Early Breast Cancer Treatment

December 7, 2011

SAN ANTONIO — Obesity is associated with worse outcomes overall in early-stage breast cancer, researchers reported at the 2011 CTRC-AACR San...

Oral Bisphosphonate Did Not Improve Prognosis for Patients With Breast Cancer

December 7, 2011

SAN ANTONIO — Results from a German study demonstrated no improvement in disease-free survival among patients with breast cancer who were...

Clodronate Appeared Safe, Modestly Affected Breast Cancer Disease Events

December 7, 2011

SAN ANTONIO — A recently presented study revealed that the bisphosphonate clodronate had a low incidence of adverse events and toxicity among...

Institute of Medicine to Release Report on Breast Cancer and the Environment

December 7, 2011

SAN ANTONIO — Although women have little or no control over some of the risk factors for breast cancer, such as those related to aging and...

Immediate Bisphosphonate Use With Endocrine Therapy Reduced Recurrence, Increased Survival in Postmenopausal Early Breast Cancer

December 7, 2011

SAN ANTONIO — The addition of zoledronic acid to adjuvant endocrine therapy increased bone mineral density and reduced the risk for disease...

Zoledronic Acid Shows Long-Term Benefit in Survivorship for Premenopausal ER-Positive Breast Cancer

December 7, 2011

SAN ANTONIO — Researchers have proven the continuing effectiveness of treating patients with estrogen receptor-positive premenopausal breast...

Molecular Differences May Be Used to Predict Early vs. Late Hormone Receptor-Positive Breast Cancer Recurrence

December 6, 2011

SAN ANTONIO — Researchers may have discovered a series of genes that will help predict whether or not a woman with hormone receptor-positive...

Diabetes and Obesity Increase Risk for Breast Cancer Development

December 6, 2011

SAN ANTONIO — Having diabetes or being obese after age 60 significantly increases the risk for developing breast cancer, a Swedish study has...

Page:   1 2 3 4 5 6 7 8 9 10  next
Results Per Page